about
Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease.Conjugated equine estrogens and colorectal cancer incidence and survival: the Women's Health Initiative randomized clinical trial.Estrogen plus progestin and the risk of coronary heart disease.Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial.Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial.Effects of conjugated equine estrogen on health-related quality of life in postmenopausal women with hysterectomy: results from the Women's Health Initiative Randomized Clinical Trial.Calcium plus vitamin D supplementation and the risk of fractures.Calcium/vitamin D supplementation and cardiovascular events.Prehypertension and cardiovascular disease risk in the Women's Health Initiative.Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women's Health Initiative.Arthritis increases the risk for fractures--results from the Women's Health InitiativeUsefulness of baseline lipids and C-reactive protein in women receiving menopausal hormone therapy as predictors of treatment-related coronary eventsObesity and risk of pancreatic cancer among postmenopausal women: the Women's Health Initiative (United States).Effects of postmenopausal hormone therapy on rheumatoid arthritis: the women's health initiative randomized controlled trials.Low-fat, increased fruit, vegetable, and grain dietary pattern, fractures, and bone mineral density: the Women's Health Initiative Dietary Modification Trial.Calcium, vitamin D supplementation, and physical function in the Women's Health InitiativeEffect of calcium and vitamin D supplementation on blood pressure: the Women's Health Initiative Randomized Trial.Estrogen plus progestin and breast cancer detection by means of mammography and breast biopsy.Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health Initiative.Estrogen plus progestin and the risk of peripheral arterial disease: the Women's Health Initiative.Effects of estrogen plus progestin on health-related quality of life.Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial.Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial.Estrogen plus progestin and colorectal cancer in postmenopausal women.Estrogen plus progestin and risk of venous thrombosis.Predicting risk of breast cancer in postmenopausal women by hormone receptor status.Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative.
P50
Q33234184-9FDC708D-1516-43E2-A5E4-CA67951B34F5Q34118386-1750AD33-140A-4FD1-A5B4-5786E5FEA0B2Q34220432-A23F0971-51E3-4674-848C-D33219526B7FQ34266403-C3460B74-4260-46CC-84C7-F70581A41502Q34370566-7F45366F-C078-4133-B945-A9D0B29E33DEQ34454139-879646D0-E67E-431C-9275-A6C2560191DDQ34495055-DFA089CD-E9D2-42AC-8FAE-6C557C4C2FA8Q34575880-056F4D17-91DF-4EEC-9572-EDA5362816C3Q34575884-AA7B046A-F91B-4BFA-9799-AE7D2904DFB3Q34611511-1E0C9484-672A-48E5-A932-F6C6174B0298Q35146096-D9B9F0E5-D737-48B7-B0A0-591C6F9A77B6Q36528400-C993FAC9-70BD-469A-963D-2D24752A419FQ36858085-C94DFAA0-6D98-473B-B512-54C1EF59B323Q37140905-1E1908B5-445E-4D1F-B4D9-8B73BD651253Q37194468-4EFDC038-2231-47F3-B358-DB7CB8C5C381Q37419523-A9927EB9-9878-402F-9BFF-9CCF3850E35EQ37470980-3EB21F70-116C-4405-BBE7-82A5449F2FADQ38391997-02FC422F-76CA-435C-BAC7-DEBD2CEEF007Q39367613-D5CA7E13-53F9-424B-9AB4-036EBC7F3B85Q44055769-0693ED09-3239-4100-8725-EC0B0F6F6C61Q44365557-ACDBDF28-34F2-4254-9787-C6228939164EQ44461473-30CA5446-184F-45D7-8DE9-DF4844AD26EFQ44602959-14CE7050-5192-4970-9894-591BC1F1740FQ44785535-4566EB6D-6F2E-499A-8393-1416804D1A41Q45092058-5D95FCAF-0CD9-41AE-8371-BD5C4EA9B28DQ46901894-08812C9C-D33A-4A34-A6FC-174C3987C779Q46943209-0FA77F6F-923A-4EA7-9DF9-ACFDDA9F19E8
P50
name
Women's Health Initiative Investigators
@en
type
label
Women's Health Initiative Investigators
@en
prefLabel
Women's Health Initiative Investigators
@en